I am...
- All
- HLH/FEL/FHL
- LCH
- Rare Histiocytic Disorders and Other Topics
- RDD
Heterogeneity in Histiocytosis associated Neurodegeneration using iPSC models
Principal Investigator: Nicole Coufal, MD University of California, San Diego La Jolla, CA USA Date of Award:…
Burden of morbidity and premature mortality in patients with Langerhans cell histiocytosis
Principal Investigator: Dr. Gaurav Goyal University of Alabama Birmingham, AL Date of Award: December 2022 Amount of…
A Study of the Spectrum of Visual Function and Choroidal Structure in Patients with Histiocytosis
Principal Investigator: Dr. Jasmine Francis Memorial Sloan Kettering Cancer Center New York City, NY USA Date…
Modeling Langerhans cell Histiocytosis with patient-derived iPSCs
Principal Investigator Dr. Giulio Abagnale St.Anna Children’s Cancer Research Institute Vienna, Austria Date of Award December 2021…
Mapping and understanding the heterogeneity of Langerhans cell histiocytosis using single-cell analysis
Florent Ginhoux Singapore Immunology Network (SIgN) / A*STAR, Singapore
Developmental Hierarchy in LCH
Principal Investigator Caroline Hutter St. Anna Kinderkrebsforschung Vienna, Austria Date of Award December 2018 Amount of Award…
Maintenance of the IT platform of the LCH-IV Treatment Protocol Study (LCH-IVTPS)
Principal Investigator Milen Minkov CCRI, St. Anna Kinderkrebsforschung Vienna, Austria Date of Award December 2017 Amount of…
Innate T cells in Langerhan’s Cell Histiocytosis
Principal Investigator Stuart Berzins, Ph.D. Federation University Australia Ballarat, Victoria, Australia Date of Award December 2016 Amount…
The Interplay of NOTCH and MAPK Pathway in LCH
Principal Investigator Raphaela Schwentner, MSc, PhD Children’s Cancer Research Institute Vienna, Austria Date of Award December…
LCH-IV Clinical Trial – Stratum I Patient Registration Reimbursement for North American Institutions
Principal Investigator Carlos Rodriguez-Galindo, MD St. Jude Children’s Research Hospital Memphis, Tennessee USA Date of Award…